Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anti-JNKs Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4612911
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Anti-JNKs antibody is an immunoglobulin directed against JNKs (c-Jun N-terminal kinases, c-Jun N-terminal kinases). Such antibodies are usually produced by immunizing animals (such as mice, rabbits, etc.) and have the ability to specifically bind to JNKs proteins. JNKs are part of the MAPK (Mitogen-Activated Protein Kinases) family and are involved in regulating important biological processes such as cell growth, differentiation, and apoptosis. Anti-JNKs antibodies can be used in immunological techniques, such as Western blotting, immunohistochemistry, etc., to detect, localize and quantify the expression levels of JNKs in cells or tissues to further study their functions and related disease mechanisms.
According to our (Global Info Research) latest study, the global Anti-JNKs Antibodies market size was valued at US$ 36.3 million in 2023 and is forecast to a readjusted size of USD 52.7 million by 2030 with a CAGR of 5.4% during review period.
Because JNKs (c-Jun N-terminal kinases) play a key role in multiple biological processes such as apoptosis, inflammation, and tumorigenesis, the demand for anti-JNKs antibodies in scientific research and clinical applications continues to grow. Especially in tumor research and treatment, anti-JNKs antibodies have become an important research tool and treatment method. In addition to traditional scientific research fields, the application of anti-JNKs antibodies in drug development and clinical treatment is also expanding. For example, some anti-JNKs antibodies have been used to develop new anti-cancer drugs, showing good efficacy and prospects. In summary, the anti-JNKs antibody market has broad development prospects and huge market potential.
This report is a detailed and comprehensive analysis for global Anti-JNKs Antibodies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Anti-JNKs Antibodies market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-JNKs Antibodies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-JNKs Antibodies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Anti-JNKs Antibodies market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-JNKs Antibodies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-JNKs Antibodies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cell Signaling Technology, Abcam, Santa Cruz Biotechnology, R&D Systems, Thermo Fisher Scientific, Sigma-Aldrich, MilliporeSigma, OriGene Technologies, BioLegend, Proteintech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Anti-JNKs Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Chain Antibody
Other
Market segment by Application
Western Blot
Immunohistochemistry
Other
Major players covered
Cell Signaling Technology
Abcam
Santa Cruz Biotechnology
R&D Systems
Thermo Fisher Scientific
Sigma-Aldrich
MilliporeSigma
OriGene Technologies
BioLegend
Proteintech
Enzo Life Sciences
Fcmacs Biotech
APExBIO
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-JNKs Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-JNKs Antibodies, with price, sales quantity, revenue, and global market share of Anti-JNKs Antibodies from 2019 to 2024.
Chapter 3, the Anti-JNKs Antibodies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-JNKs Antibodies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Anti-JNKs Antibodies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-JNKs Antibodies.
Chapter 14 and 15, to describe Anti-JNKs Antibodies sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anti-JNKs Antibodies Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Single Chain Antibody
    • 1.3.3 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anti-JNKs Antibodies Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Western Blot
    • 1.4.3 Immunohistochemistry
    • 1.4.4 Other
  • 1.5 Global Anti-JNKs Antibodies Market Size & Forecast
    • 1.5.1 Global Anti-JNKs Antibodies Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Anti-JNKs Antibodies Sales Quantity (2019-2030)
    • 1.5.3 Global Anti-JNKs Antibodies Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Cell Signaling Technology
    • 2.1.1 Cell Signaling Technology Details
    • 2.1.2 Cell Signaling Technology Major Business
    • 2.1.3 Cell Signaling Technology Anti-JNKs Antibodies Product and Services
    • 2.1.4 Cell Signaling Technology Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cell Signaling Technology Recent Developments/Updates
  • 2.2 Abcam
    • 2.2.1 Abcam Details
    • 2.2.2 Abcam Major Business
    • 2.2.3 Abcam Anti-JNKs Antibodies Product and Services
    • 2.2.4 Abcam Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abcam Recent Developments/Updates
  • 2.3 Santa Cruz Biotechnology
    • 2.3.1 Santa Cruz Biotechnology Details
    • 2.3.2 Santa Cruz Biotechnology Major Business
    • 2.3.3 Santa Cruz Biotechnology Anti-JNKs Antibodies Product and Services
    • 2.3.4 Santa Cruz Biotechnology Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Santa Cruz Biotechnology Recent Developments/Updates
  • 2.4 R&D Systems
    • 2.4.1 R&D Systems Details
    • 2.4.2 R&D Systems Major Business
    • 2.4.3 R&D Systems Anti-JNKs Antibodies Product and Services
    • 2.4.4 R&D Systems Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 R&D Systems Recent Developments/Updates
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Anti-JNKs Antibodies Product and Services
    • 2.5.4 Thermo Fisher Scientific Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.6 Sigma-Aldrich
    • 2.6.1 Sigma-Aldrich Details
    • 2.6.2 Sigma-Aldrich Major Business
    • 2.6.3 Sigma-Aldrich Anti-JNKs Antibodies Product and Services
    • 2.6.4 Sigma-Aldrich Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sigma-Aldrich Recent Developments/Updates
  • 2.7 MilliporeSigma
    • 2.7.1 MilliporeSigma Details
    • 2.7.2 MilliporeSigma Major Business
    • 2.7.3 MilliporeSigma Anti-JNKs Antibodies Product and Services
    • 2.7.4 MilliporeSigma Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 MilliporeSigma Recent Developments/Updates
  • 2.8 OriGene Technologies
    • 2.8.1 OriGene Technologies Details
    • 2.8.2 OriGene Technologies Major Business
    • 2.8.3 OriGene Technologies Anti-JNKs Antibodies Product and Services
    • 2.8.4 OriGene Technologies Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 OriGene Technologies Recent Developments/Updates
  • 2.9 BioLegend
    • 2.9.1 BioLegend Details
    • 2.9.2 BioLegend Major Business
    • 2.9.3 BioLegend Anti-JNKs Antibodies Product and Services
    • 2.9.4 BioLegend Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 BioLegend Recent Developments/Updates
  • 2.10 Proteintech
    • 2.10.1 Proteintech Details
    • 2.10.2 Proteintech Major Business
    • 2.10.3 Proteintech Anti-JNKs Antibodies Product and Services
    • 2.10.4 Proteintech Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Proteintech Recent Developments/Updates
  • 2.11 Enzo Life Sciences
    • 2.11.1 Enzo Life Sciences Details
    • 2.11.2 Enzo Life Sciences Major Business
    • 2.11.3 Enzo Life Sciences Anti-JNKs Antibodies Product and Services
    • 2.11.4 Enzo Life Sciences Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Enzo Life Sciences Recent Developments/Updates
  • 2.12 Fcmacs Biotech
    • 2.12.1 Fcmacs Biotech Details
    • 2.12.2 Fcmacs Biotech Major Business
    • 2.12.3 Fcmacs Biotech Anti-JNKs Antibodies Product and Services
    • 2.12.4 Fcmacs Biotech Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Fcmacs Biotech Recent Developments/Updates
  • 2.13 APExBIO
    • 2.13.1 APExBIO Details
    • 2.13.2 APExBIO Major Business
    • 2.13.3 APExBIO Anti-JNKs Antibodies Product and Services
    • 2.13.4 APExBIO Anti-JNKs Antibodies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 APExBIO Recent Developments/Updates

3 Competitive Environment: Anti-JNKs Antibodies by Manufacturer

  • 3.1 Global Anti-JNKs Antibodies Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Anti-JNKs Antibodies Revenue by Manufacturer (2019-2024)
  • 3.3 Global Anti-JNKs Antibodies Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Anti-JNKs Antibodies by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Anti-JNKs Antibodies Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Anti-JNKs Antibodies Manufacturer Market Share in 2023
  • 3.5 Anti-JNKs Antibodies Market: Overall Company Footprint Analysis
    • 3.5.1 Anti-JNKs Antibodies Market: Region Footprint
    • 3.5.2 Anti-JNKs Antibodies Market: Company Product Type Footprint
    • 3.5.3 Anti-JNKs Antibodies Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anti-JNKs Antibodies Market Size by Region
    • 4.1.1 Global Anti-JNKs Antibodies Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Anti-JNKs Antibodies Consumption Value by Region (2019-2030)
    • 4.1.3 Global Anti-JNKs Antibodies Average Price by Region (2019-2030)
  • 4.2 North America Anti-JNKs Antibodies Consumption Value (2019-2030)
  • 4.3 Europe Anti-JNKs Antibodies Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Anti-JNKs Antibodies Consumption Value (2019-2030)
  • 4.5 South America Anti-JNKs Antibodies Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Anti-JNKs Antibodies Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 5.2 Global Anti-JNKs Antibodies Consumption Value by Type (2019-2030)
  • 5.3 Global Anti-JNKs Antibodies Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 6.2 Global Anti-JNKs Antibodies Consumption Value by Application (2019-2030)
  • 6.3 Global Anti-JNKs Antibodies Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 7.2 North America Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 7.3 North America Anti-JNKs Antibodies Market Size by Country
    • 7.3.1 North America Anti-JNKs Antibodies Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Anti-JNKs Antibodies Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 8.2 Europe Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 8.3 Europe Anti-JNKs Antibodies Market Size by Country
    • 8.3.1 Europe Anti-JNKs Antibodies Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Anti-JNKs Antibodies Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Anti-JNKs Antibodies Market Size by Region
    • 9.3.1 Asia-Pacific Anti-JNKs Antibodies Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Anti-JNKs Antibodies Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 10.2 South America Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 10.3 South America Anti-JNKs Antibodies Market Size by Country
    • 10.3.1 South America Anti-JNKs Antibodies Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Anti-JNKs Antibodies Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anti-JNKs Antibodies Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Anti-JNKs Antibodies Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Anti-JNKs Antibodies Market Size by Country
    • 11.3.1 Middle East & Africa Anti-JNKs Antibodies Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Anti-JNKs Antibodies Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Anti-JNKs Antibodies Market Drivers
  • 12.2 Anti-JNKs Antibodies Market Restraints
  • 12.3 Anti-JNKs Antibodies Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anti-JNKs Antibodies and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anti-JNKs Antibodies
  • 13.3 Anti-JNKs Antibodies Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anti-JNKs Antibodies Typical Distributors
  • 14.3 Anti-JNKs Antibodies Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anti-JNKs Antibodies. Industry analysis & Market Report on Anti-JNKs Antibodies is a syndicated market report, published as Global Anti-JNKs Antibodies Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Anti-JNKs Antibodies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,651.76
    		3,977.64
    		5,303.52
    		3,138.96
    		4,708.44
    		6,277.92
    		490,540.80
    		735,811.20
    		981,081.60
    		292,180.80
    		438,271.20
    		584,361.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo